首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
【24h】

Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.

机译:急性缺血性中风的氧化应激和基质金属蛋白酶9:中风抗氧化疗法的生物标志物评估(BEAT-中风)研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Experimental stroke studies indicate that oxidative stress is a major contributing factor to ischemic cerebral injury. Oxidative stress is also implicated in activation of matrix metalloproteinases (MMPs) and blood-brain barrier injury after ischemia-reperfusion. Plasma biomarkers of oxidative stress may have utility as early indicators of efficacy in Phase 2 trials of antioxidant therapies in human stroke. To date, a valid biomarker has been unavailable. We measured F2-isoprostanes (F2IPs), free-radical induced products of neuronal arachadonic acid peroxidation, in acute ischemic stroke. We aimed to determine the change in plasma F2IP levels over time and relationship with plasma MMP-9 in tPA-treated and tPA-untreated stroke patients. METHODS: We performed a case-control study of consecutive ischemic stroke patients (25 tPA-treated and 27 tPA-untreated) presenting within 8 hours of stroke onset. Controls were individuals without prior stroke from a primary care clinic network serving the source population from which cases were derived. Infarct volume was determined on acute diffusion-weighted MRI (DWI) performed within 48 hours using a semi-automated computerized segmentation algorithm. Phlebotomy was performed at <8 hours, 24 hours, 2 to 5 days, and 4 to 6 weeks. F2IPs were measured by gas chromatography/mass spectrometry and MMP-9 by ELISA. Prestroke antioxidant dietary intake was measured by the 24-hour recall method. RESULTS: In 52 cases and 27 controls, early (median 6 hours postonset) F2IPs were elevated in stroke cases compared with controls (medians 0. 041 versus 0.0295 pg/mL, P=0.012). No difference in F2IPSs was present at later time points. Early plasma F2IPs correlated with MMP-9 in all patients (P=0.01) and the tPA-treated subgroup (P=0.02). No correlation was found with NIHSS, DWI infarct volume, 90-day Rankin score, or C-reactive protein (P>0.05 for all). CONCLUSIONS: In early human stroke we found evidence of increased oxidative stress and a relationship with MMP-9expression, supporting findings from experimental studies.
机译:背景与目的:实验性中风研究表明,氧化应激是缺血性脑损伤的主要因素。缺血再灌注后,氧化应激还与基质金属蛋白酶(MMPs)激活和血脑屏障损伤有关。氧化应激的血浆生物标志物可能在人类中风的抗氧化剂治疗的2期试验中作为效用的早期指标有用。迄今为止,有效的生物标记尚不可用。我们在急性缺血性中风中测量了神经元花生四烯酸过氧化的自由基诱导产物F2-异前列腺素(F2IPs)。我们旨在确定tPA治疗和tPA未治疗的中风患者血浆F2IP水平随时间的变化以及与血浆MMP-9的关系。方法:我们对卒中发作后8小时内出现的连续缺血性卒中患者(25 tPA治疗和27 tPA未治疗)进行了病例对照研究。对照是没有初级卒中的个人,该初级卒中来自服务于来源病例的基层医疗诊所网络。使用半自动计算机分割算法,在48小时内通过急性弥散加权MRI(DWI)确定梗塞体积。采血在<8小时,24小时,2至5天和4至6周进行。通过气相色谱/质谱法测量F2IP,通过ELISA测量MMP-9。脑卒中前抗氧化剂的饮食摄入量通过24小时召回方法进行测量。结果:在52例和27例对照中,中风病例的早期(发病后6小时中)F2IPs较对照升高(中位数为0.041对0.0295 pg / mL,P = 0.012)。在以后的时间点,F2IPS没有差异。在所有患者(t = 0.01)和tPA治疗的亚组(P = 0.02)中,早期血浆F2IP与MMP-9相关。与NIHSS,DWI梗死体积,90天Rankin评分或C反应蛋白无相关性(所有P> 0.05)。结论:在早期人类中风中,我们发现了氧化应激增加的证据,并且与MMP-9表达有关,这支持了实验研究的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号